Variant report
Variant | esv1838254 |
---|---|
Chromosome Location | chr14:105366499-105373951 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:38)
- CpG islands (count:427)
- Chromatin interactive region (count:5)
- LncRNA region (count:3)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:38 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CBX3 | chr14:105369835-105370253 | K562 | blood: | n/a | n/a |
2 | CTCF | chr14:105369860-105370010 | WI-38 | lung: | n/a | n/a |
3 | E2F4 | chr14:105367909-105367917 | MCF10A-Er-Src | breast: | n/a | n/a |
4 | EP300 | chr14:105372130-105372777 | GM12878 | blood: | n/a | n/a |
5 | EP300 | chr14:105371734-105372019 | GM12878 | blood: | n/a | n/a |
6 | FAM48A | chr14:105370679-105370852 | GM12878 | blood: | n/a | n/a |
7 | GABPA | chr14:105371543-105371746 | Hela-S3 | cervix: | n/a | n/a |
8 | GABPA | chr14:105371809-105373361 | HepG2 | liver: | n/a | n/a |
9 | GABPA | chr14:105371814-105372098 | Hela-S3 | cervix: | n/a | n/a |
10 | KAP1 | chr14:105369649-105370177 | K562 | blood: | n/a | n/a |
11 | KAP1 | chr14:105373638-105374358 | HEK293 | kidney: | n/a | n/a |
12 | KAP1 | chr14:105373453-105374272 | K562 | blood: | n/a | n/a |
13 | MAFK | chr14:105373360-105373399 | HepG2 | liver: | n/a | n/a |
14 | NFIC | chr14:105371264-105371628 | ECC-1 | luminal epithelium: | n/a | n/a |
15 | PAX5 | chr14:105372391-105372604 | GM12878 | blood: | n/a | n/a |
16 | PAX5 | chr14:105371487-105371692 | GM12878 | blood: | n/a | n/a |
17 | POLR2A | chr14:105372898-105373159 | H1-hESC | embryonic stem cell: | n/a | n/a |
18 | POLR2A | chr14:105367213-105367324 | GM12878 | blood: | n/a | n/a |
19 | POU2F2 | chr14:105371500-105372774 | GM12878 | blood: | n/a | n/a |
20 | REST | chr14:105371505-105373047 | HepG2 | liver: | n/a | n/a |
21 | REST | chr14:105371445-105373369 | U87 | brain: | n/a | n/a |
22 | REST | chr14:105371472-105373380 | PANC-1 | pancreas: | n/a | n/a |
23 | RUNX3 | chr14:105367307-105367746 | GM12878 | blood: | n/a | n/a |
24 | RUNX3 | chr14:105367381-105367721 | GM12878 | blood: | n/a | n/a |
25 | SETDB1 | chr14:105373608-105374217 | U2OS | brain: | n/a | n/a |
26 | SETDB1 | chr14:105369833-105370394 | U2OS | brain: | n/a | n/a |
27 | SPI1 | chr14:105366163-105366523 | HL-60 | blood: | n/a | n/a |
28 | SPI1 | chr14:105371068-105371333 | GM12891 | blood: | n/a | n/a |
29 | SPI1 | chr14:105366225-105366507 | GM12891 | blood: | n/a | n/a |
30 | SRF | chr14:105371492-105372860 | GM12878 | blood: | n/a | n/a |
31 | STAT3 | chr14:105369951-105370137 | MCF10A-Er-Src | breast: | n/a | n/a |
32 | STAT3 | chr14:105367453-105367782 | MCF10A-Er-Src | breast: | n/a | n/a |
33 | TAL1 | chr14:105369602-105369880 | K562 | blood: | n/a | n/a |
34 | TCF12 | chr14:105371182-105371665 | ECC-1 | luminal epithelium: | n/a | n/a |
35 | TCF12 | chr14:105371166-105371643 | ECC-1 | luminal epithelium: | n/a | n/a |
36 | TCF3 | chr14:105371367-105373381 | GM12878 | blood: | n/a | n/a |
37 | ZNF143 | chr14:105373743-105373752 | H1-hESC | embryonic stem cell: | n/a | n/a |
38 | ZNF143 | chr14:105369913-105370201 | K562 | blood: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr14:105371541-105371591 | Caco-2 | colon: | n/a |
2 | chr14:105370983-105371033 | HEEpiC | esophagus: | n/a |
3 | chr14:105370983-105371033 | SK-N-SH | brain: | n/a |
4 | chr14:105372186-105372236 | BJ | skin: | n/a |
5 | chr14:105373082-105373132 | SK-N-SH_RA | brain: | n/a |
6 | chr14:105370983-105371033 | AG09319 | gingival: | n/a |
7 | chr14:105368685-105368735 | HAEpiC | amniotic membrane: | n/a |
8 | chr14:105368685-105368735 | HNPCEpiC | eye: | n/a |
9 | chr14:105371541-105371591 | AG10803 | skin: | n/a |
10 | chr14:105371541-105371591 | Hepatocyte | liver: | n/a |
11 | chr14:105372846-105372896 | GM12891 | blood: | n/a |
12 | chr14:105372846-105372896 | HPAEpiC | pulmonary alveolar: | n/a |
13 | chr14:105370983-105371033 | U87 | brain: | n/a |
14 | chr14:105373391-105373441 | PANC-1 | pancreas: | n/a |
15 | chr14:105372186-105372236 | NB4 | blood: | n/a |
16 | chr14:105372186-105372236 | AG04450 | lung: | fetal |
17 | chr14:105373082-105373132 | NB4 | blood: | n/a |
18 | chr14:105371541-105371591 | ECC-1 | luminal epithelium: | n/a |
19 | chr14:105372186-105372236 | AG10803 | skin: | n/a |
20 | chr14:105372846-105372896 | BE2_C | brain: | n/a |
21 | chr14:105372846-105372896 | HCF | heart: | n/a |
22 | chr14:105370983-105371033 | HIPEpiC | eye: | n/a |
23 | chr14:105372186-105372236 | ovcar-3 | ovarian: | n/a |
24 | chr14:105372846-105372896 | SKMC | muscle: | n/a |
25 | chr14:105371541-105371591 | K562 | blood: | n/a |
26 | chr14:105372186-105372236 | Jurkat | blood: | n/a |
27 | chr14:105370983-105371033 | GM12891 | blood: | n/a |
28 | chr14:105371541-105371591 | CMK | blood: | n/a |
29 | chr14:105373391-105373441 | A549 | lung: | n/a |
30 | chr14:105372846-105372896 | GM19239 | blood: | n/a |
31 | chr14:105371541-105371591 | AG04449 | skin: | fetal |
32 | chr14:105373082-105373132 | LNCaP | prostate: | n/a |
33 | chr14:105372846-105372896 | GM12878 | blood: | n/a |
34 | chr14:105372186-105372236 | NHDF-neo | bronchial: | n/a |
35 | chr14:105368685-105368735 | ProgFib | skin: | n/a |
36 | chr14:105372186-105372236 | LNCaP | prostate: | n/a |
37 | chr14:105370983-105371033 | ECC-1 | luminal epithelium: | n/a |
38 | chr14:105372846-105372896 | HRCEpiC | kidney: | n/a |
39 | chr14:105368685-105368735 | HUVEC | blood vessel: | n/a |
40 | chr14:105372186-105372236 | HEEpiC | esophagus: | n/a |
41 | chr14:105368685-105368735 | SK-N-MC | brain: | n/a |
42 | chr14:105371541-105371591 | HNPCEpiC | eye: | n/a |
43 | chr14:105371541-105371591 | H1-hESC | embryonic stem cell: | embryo |
44 | chr14:105371541-105371591 | PFSK-1 | brain: | n/a |
45 | chr14:105370983-105371033 | MCF10A-Er-Src | breast: | n/a |
46 | chr14:105368685-105368735 | NH-A | brain: | n/a |
47 | chr14:105372846-105372896 | HNPCEpiC | eye: | n/a |
48 | chr14:105372846-105372896 | ECC-1 | luminal epithelium: | n/a |
49 | chr14:105370983-105371033 | SKMC | muscle: | n/a |
50 | chr14:105372186-105372236 | RPTEC | kidney: | n/a |
(count:5 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr14:105360836..105362867-chr14:105365317..105367503,2 | K562 | blood: | |
2 | chr14:105359525..105362336-chr14:105366003..105367947,2 | K562 | blood: | |
3 | chr14:105364425..105366237-chr14:105368501..105370477,2 | K562 | blood: | |
4 | chr14:105359445..105362307-chr14:105370488..105372774,2 | MCF-7 | breast: | |
5 | chr14:105365193..105367745-chr14:105399799..105401436,2 | K562 | blood: |
(count:3 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-KIAA0284-1 | chr14:105371474-105371541 | ENSG00000259067 |
2 | lnc-KIAA0284-1 | chr14:105371069-105371327 | ENSG00000259067 |
3 | lnc-KIAA0284-1 | chr14:105370679-105370935 | ENSG00000259067 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000259067 | TF binding region |
ENSG00000259067 | CpG island |
ENSG00000099814 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs920499 | chr14:105366499-105366500 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs374910830 | chr14:105366519-105366520 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
3 | rs115755284 | chr14:105366520-105366521 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
4 | rs545031724 | chr14:105366607-105366608 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs111382676 | chr14:105366645-105366646 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs558815659 | chr14:105366667-105366668 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs151101377 | chr14:105366688-105366689 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs544507735 | chr14:105366692-105366693 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs2582538 | chr14:105366721-105366722 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs141043461 | chr14:105366761-105366762 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs2841247 | chr14:105366762-105366763 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs559958343 | chr14:105366770-105366771 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs532144456 | chr14:105366800-105366801 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs150227122 | chr14:105366805-105366806 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs370977659 | chr14:105366830-105366831 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs568834401 | chr14:105366871-105366872 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs531152343 | chr14:105366877-105366878 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs550849502 | chr14:105366910-105366911 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs531645142 | chr14:105366922-105366923 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs80079114 | chr14:105366940-105366941 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs76780023 | chr14:105366942-105366943 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs567539074 | chr14:105366954-105366955 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs375924301 | chr14:105366977-105366978 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs531188872 | chr14:105367015-105367016 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs116784275 | chr14:105367034-105367035 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs116500112 | chr14:105367035-105367036 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs566804567 | chr14:105367046-105367047 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs187175138 | chr14:105367055-105367056 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs113424551 | chr14:105367071-105367072 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs192326146 | chr14:105367111-105367112 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs373688910 | chr14:105367183-105367184 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs140581279 | chr14:105367194-105367195 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs184535795 | chr14:105367199-105367200 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs373074653 | chr14:105367286-105367287 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
35 | rs190121094 | chr14:105367352-105367353 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
36 | rs536420390 | chr14:105367354-105367355 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
37 | rs182177580 | chr14:105367367-105367368 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
38 | rs547202878 | chr14:105367368-105367369 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
39 | rs560198427 | chr14:105367378-105367379 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
40 | rs35161267 | chr14:105367409-105367410 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
41 | rs532157670 | chr14:105367480-105367481 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
42 | rs56691735 | chr14:105367518-105367519 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs185620807 | chr14:105367562-105367563 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
44 | rs531189853 | chr14:105367596-105367597 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
45 | rs74635881 | chr14:105367728-105367729 | Weak transcription Flanking Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
46 | rs566198412 | chr14:105367756-105367757 | Weak transcription Flanking Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
47 | rs145650150 | chr14:105367757-105367758 | Weak transcription Flanking Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
48 | rs561202737 | chr14:105367778-105367779 | Weak transcription Flanking Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
49 | rs530233300 | chr14:105367811-105367812 | Weak transcription Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs80343483 | chr14:105367826-105367827 | Weak transcription Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 17899364 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Chronic myeloid leukemia | 20724749 | CNVD |
Wilms tumour | 21544195 | CNVD |
Lung cancer | 18438408 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
cataract | 16735990 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Developmental delay | 21147756 | CNVD |
Cancer | 20164920 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Biliary cancer | 19435499 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Acute lymphoblastic leukemia | 20139093 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Non-small cell lung cancer | 18320023 | CNVD |
Melanoma | 17363583 | CNVD |
Prostate cancer | 18632612 | CNVD |
Congenital heart defect | 22367666 | CNVD |
Developmental delay | 22367666 | CNVD |
Genitourinary abnormalities | 22367666 | CNVD |
Intellectual disability | 22367666 | CNVD |
Microcephaly | 22367666 | CNVD |
Muscularhypotonia | 22367666 | CNVD |
Ocular coloboma | 22367666 | CNVD |
Teratozoospermia | 22367666 | CNVD |
Cervical cancer | 21062161 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Breast cancer | 21990379 | CNVD |
Breast cancer | 16417655 | CNVD |
22q11 deletion syndrome | 22511897 | CNVD |
Cancer | 21129771 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Schizophrenia | 21399695 | CNVD |
Intracranial ependymoma | 16609018 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
14q deletion syndrome | 22511897 | CNVD |
Epilepsy | 22083797 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Cancer | 17440070 | CNVD |
Neurocytoma | 17123091 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Central neurocytomas | 17123091 | CNVD |
Acute lymphoblastic leukemia | 17315016 | CNVD |
Lung cancer | 17086460 | CNVD |
Mortal | 21835882 | CNVD |
Breast cancer | 21364760 | CNVD |
small cell lung cancer | 17426248 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Schizophrenia | 20967226 | CNVD |
Non-syndromic sensorineural hearing loss | 19587683 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Schizophrenia | 23813976 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Cancer | 20164919 | CNVD |
small cell lung cancer | 20016488 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr14:105354000-105369800 | Weak transcription | HSMMtube | muscle |
2 | chr14:105355400-105367000 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
3 | chr14:105362600-105368200 | Weak transcription | Foreskin Keratinocyte Primary Cells skin02 | Skin |
4 | chr14:105364200-105366600 | Weak transcription | Pancreas | Pancrea |
5 | chr14:105365800-105370800 | Weak transcription | Fetal Lung | lung |
6 | chr14:105366200-105367600 | Enhancers | GM12878-XiMat | blood |
7 | chr14:105366600-105366800 | Enhancers | Pancreas | Pancrea |
8 | chr14:105367600-105368000 | Flanking Active TSS | GM12878-XiMat | blood |
9 | chr14:105368000-105369600 | Weak transcription | GM12878-XiMat | blood |
10 | chr14:105369600-105371400 | ZNF genes & repeats | GM12878-XiMat | blood |
11 | chr14:105369800-105371000 | ZNF genes & repeats | HSMMtube | muscle |
12 | chr14:105370800-105371000 | Bivalent Enhancer | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
13 | chr14:105370800-105371000 | Bivalent Enhancer | H9 Derived Neuron Cultured Cells | ES cell derived |
14 | chr14:105370800-105371000 | Bivalent Enhancer | Primary B cells from peripheral blood | blood |
15 | chr14:105370800-105371000 | Bivalent Enhancer | Fetal Muscle Leg | muscle |
16 | chr14:105370800-105371400 | Bivalent Enhancer | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
17 | chr14:105370800-105371400 | Enhancers | Fetal Lung | lung |
18 | chr14:105371000-105371200 | Bivalent/Poised TSS | Small Intestine | intestine |
19 | chr14:105371000-105371400 | Bivalent Enhancer | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
20 | chr14:105371000-105371400 | Flanking Active TSS | Ganglion Eminence derived primary cultured neurospheres | brain |
21 | chr14:105371000-105371600 | Bivalent Enhancer | Cortex derived primary cultured neurospheres | brain |
22 | chr14:105371200-105371400 | Bivalent Enhancer | Rectal Mucosa Donor 29 | rectum |
23 | chr14:105373400-105373600 | Bivalent Enhancer | H1 Derived Mesenchymal Stem Cells | ES cell derived |